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Introduction
Some of the rheumatoid arthritis (RA) risk allele variants
were related to tumor necrosis factor (TNF) signaling
pathways which raised the hypothesis that they might
influence the response to anti-TNF drugs.
The primary aim of our work was to investigate poten-
tial association between the HLA-DRB1 and RA risk alleles
specifically selected for their relevance on RA biologic
pathways with the response to anti-TNF treatment in a
Southern European population using a nationwide
register.
Methods
We evaluated 383 RA patients for associations between
anti-TNF treatment response assessed by an absolute
change in DAS28 at six months as the primary outcome,
and seven single nucleotide polymorphisms (SNP). We
also studied the same association taking the proportion of
EULAR good responders and non responders at six
months as the outcome. Univariate and multivariate linear
and logistic regression analyses were performed, adjusting
for clinical variables that influenced treatment response.
Results
The minor allele (G), which is the risk allele for RA sus-
ceptibility, rs3761847 SNP in the TRAF1/C5 region was
associated with a poor anti-TNF treatment response
either in linear (coefficient -0.24; 95% confidence interval
(CI) -0.43, -0.06; p-value 0.009) and in logistic univariate
(odds ratio (OR) 0.61; CI 0.41, 0.92; p-value 0.018) and
multivariate regression analyses.
Associations between HLA-DRB1 or the other allele
variants with the response to anti-TNF treatment were
not observed.
Conclusion
The rs3761847 TRAF1/C5 risk RA locus influenced the
anti-TNF treatment response in the Southern European
population assessed in this study. Additional studies in
other populations are necessary to confirm the relevance
of this finding.
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